Petros Pharmaceuticals Inc (NASDAQ:PTPI) does about 369.01K shares in volume on a normal day but saw 62663232 shares change hands in the recent trading day. The company now has a market cap of 5.01M USD. Its current market price is $0.50, marking an increase of 87.27% compared to the previous close of $0.27. The 52 week high reached by this stock is $2.27 whilst the lowest price level in 52 weeks is $0.22.
Petros Pharmaceuticals Inc (PTPI) has a 20-day trading average at $0.3106 and the current price is -77.97% off the 52-week high compared with 126.45% distance from its 52-week low. The 50-day simple moving average of the closing price is $0.3234 and its 200-day simple moving average is $0.5470. If we look at the stock’s price movements over the week, volatility stands at 30.63%, which decreases to 15.53% over 1 month. It is also key to look at other market indicators of price movement for the stock, where we see that the relative strength index (RSI) is at 71.02 to suggest the stock is overbought.
The consensus objective for the share price is $1.00, suggesting that the stock has a potential upside of 50.0% over the period.
The current price level is 61.00%, 54.63%, and -8.60% away from its SMA20, SMA50, and SMA200 respectively, with the PTPI price moving below the 50-day SMA on current market day. Petros Pharmaceuticals Inc (PTPI) stock is up 39.28% over the week and 93.05% over the past month. Its price is -64.54% year-to-date and -64.03% over the past year.
The company’s next earnings report forecasts estimating quarterly EPS at -0.33 and -2.13 for whole year. In addition, estimates put the company’s current quarterly revenue at an average of $1.28M.
To reach the target analysts have set, the stock logically needs to grow 50.0 percent from here.
The company has a return on investment of -162.22% and return on equity of -91.54%. The beta has a value of 2.13. Price to book ratio is 1.61 and price to sales ratio is 0.72.
